14 completed. 14 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 14 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Finasteride: new trials by email Literature Review of Finasteride trials Research Report on Finasteride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia minoxidil + finasteride, Placebo foam - Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) | Phase 2 | Completed | Beijing Dayspring Pharmaceutical Technology Co., Ltd | 110 | 2024-12-05 | 2026-03-03 |
| A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 Finasteride 1mg Tablet, IVL3001 - Androgenetic Alopecia | Phase 1 / Phase 2 | Completed | Inventage Lab., Inc. | 40 | 2021-09-21 | 2022-03-04 |
| A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males Setipiprant, Placebo, Finasteride - Alopecia | Phase 2 | Completed | Allergan | 169 | 2016-07-14 | 2019-04-05 |
| Finasteride Treatment of Severe Nodulocystic Acne Finasteride 23.5 mg tablets, Finasteride 33.5 mg tablets, Placebo tablets - NODULOCYSTIC ACNE | Phase 2 | Completed | Elorac, Inc. | 106 | 2015-07-01 | 2019-02-15 |
| Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. Enzalutamide and Dutasteride or finasteride - Prostate Cancer | Phase 2 | Completed | University of Rochester | 43 | 2014-09-01 | 2024-11-13 |
| Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Finasteride - Retinal Disease | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 3 | 2010-10-01 | 2024-01-30 |
| Oral T7 Oral Testosterone in Man First Intervention (7 days), First Washout (7 days), Second Intervention (7 days) - Healthy Males, Male Contraceptive | Phase 2 | Completed | University of Washington | 11 | 2009-07-01 | 2014-01-13 |
| Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Finasteride - Retinal Disease | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 5 | 2009-02-01 | 2016-09-26 |
| Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer selenomethionine, finasteride, placebo - Prostate Cancer | Phase 2 | Completed | Roswell Park Cancer Institute | 55 | 2008-08-01 | 2023-10-02 |
| Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) 2.5 mg NX-1207, 0.125 mg NX-1207, finasteride - Benign Prostatic Hyperplasia (BPH), Enlarged Prostate | Phase 2 | Completed | Nymox Corporation | 85 | 2007-05-01 | 2012-06-14 |
| Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery Finasteride, Placebo, Prostatectomy - Adenocarcinoma of the Prostate, Stage II Prostate Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 204 | 2007-02-01 | 2016-03-09 |
| 5-Alpha Reductase and Anabolic Effects of Testosterone Testosterone Enanthate, Finasteride, Placebo - Male Hypogonadism, Muscle Atrophy | Phase 2 | Completed | VA Office of Research and Development | 60 | 2007-01-01 | 2018-10-11 |
| Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer. Flutamide, Finasteride, Placebo - Prostate Cancer, Prostatic Intraepithelial Neoplasia | Phase 2 / Phase 3 | Completed | Ente Ospedaliero Ospedali Galliera | 125 | 2004-01-01 | 2024-09-19 |
| Hormone Therapy in Treating Patients With Prostate Cancer finasteride, flutamide, quality-of-life assessment - Prostate Cancer, Sexual Dysfunction and Infertility | Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 101 | 1998-05-01 | 2016-07-04 |
Prostatic Neoplasms (5) · Alopecia (3) · Central Serous Chorioretinopathy (2) · Prostatic Hyperplasia (2) · Retinal Diseases (2) · Acne Vulgaris (1) · Eunuchism (1) · Infertility (1) · Muscular Atrophy (1) · Prostatic Intraepithelial Neoplasia (1) · Sarcopenia (1) · Sexual Dysfunction, Physiological (1)
National Eye Institute (NEI) (2) · Allergan (1) · Alliance for Clinical Trials in Oncology (1) · Beijing Dayspring Pharmaceutical Technology Co., Ltd (1) · Elorac, Inc. (1) · Ente Ospedaliero Ospedali Galliera (1) · Inventage Lab., Inc. (1) · National Cancer Institute (NCI) (1) · Nymox Corporation (1) · Roswell Park Cancer Institute (1) · University of Rochester (1) · University of Washington (1) · VA Office of Research and Development (1)
United States (11) · Australia (1) · China (1) · Italy (1)
Andrea De Censi, MD (1) · Catherine B Meyerle, MD (1) · Catherine Meyerle, M.D. (1) · Cheng Zhou, MD, PhD (1) · Chunkit Fung, M.D. (1) · James L. Mohler, MD (1) · Jeri Kim (1) · Jianzhong Zhang, MD, PhD (1) · Joan-En Lin (1) · Joel Picus, MD (1) · John K Amory, MD, MPH (1) · Scott B. Phillips, MD (1) · Stephen Borst, PhD (1)
PMID 20969601, PMID 21273946, PMID 24012740, PMID 24326421, PMID 38833144
K23HD045386 (1), N01CN35159 (1), P30CA016672 (1), U10CA031946 (1), U54HD042454 (1)